PPRO
PPRO today announces its integration of the PayPal Commerce Platform.
The move further cements PPRO’s market-leading position as one of the go-to providers of local payments infrastructure for payment service providers (PSPs), banks, and gateways.
PPRO’s integration will allow its customers to significantly reduce the time to integrate PayPal Commerce Platform solutions and give customers access to the PayPal Wallet. This development gives PPRO’s customers the opportunity to enable their merchants’ access to PayPal's user base of more than 403 million active accounts across 200 markets.
Claire Gates, Chief Commercial Officer of PPRO, said: “Today’s news marks a step forward in PPRO and PayPal’s long-standing relationship. The benefits for partners of joining PPRO’s platform are clear: we save them time and money, and provide the quality of payment method integrations that lead to high conversion rates. With the addition of the PayPal Commerce Platform - and the ability to offer the PayPal Wallet - this offering can’t be ignored by anyone operating in the global e-commerce space.”
By partnering with PPRO, PSPs, banks, platforms, and enterprises with payment platforms not only benefit from access to the PayPal Commerce Platform, but from a vast range of local payment methods (LPMs) globally. PPRO’s global payment expertise, platform engineered for performance and innovation, value through PPRO’s network of LPMs and PSPs is all accessible with just one contract and one integration. This simplicity removes complexities surrounding local payments, increases speed to market, and helps boost sales for merchants.
PPRO and PayPal will be hosting a livestream on October 7, 2021 at 11:30 CEST to discuss their partnership and how companies around the world could achieve high conversion rates by offering the payment method customers know and trust.
PPRO has established itself as one of the most trusted local payments infrastructure providers in the cross-border payments space, helping to power international growth for payment service providers, banks, gateways and enterprises with payment platforms.
The news of the PayPal Commerce Platform integration comes after PPRO announced earlier this year that it had raised US$180 million, taking the firm’s total value to over US$1 billion.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210927005059/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Canva Launches Creative Operating System30.10.2025 18:00:00 CET | Press release
Next era of Canva combines a supercharged Visual Suite, world-first design AI, and powerful tools to grow your brand Canva Design Model: World-first AI model that understands complexities and ingredients of design. AI Where You Work: Bring your imagination to life in every part of the design process, plus, a new design assistant. Video 2.0: A reimagined video editor makes professional and engaging content effortless. Canva Grow: Powerful marketing engine to ideate, create, distribute, and refine engaging ads to scale your brand. All-New Affinity: All-in-one app built by pro designers for pro designers, now forever free. Forms: Design interactive forms that can be added to any design for everything from RSVP forms to contact pages. Email Design: Design engaging emails with Canva’s drag-and-drop editor, then export to your platform of choice. Canva Code in Sheets: Seamlessly link interactive widgets with Canva Sheets to bring data to life in real time. Canva, the world’s only all-in-one
Svante Celebrates 18 Years of Carbon Management Innovation with Historic Milestones in 202530.10.2025 17:25:00 CET | Press release
Svante Technologies Inc. (Svante), a global leader in carbon capture and removal solutions, proudly marks its 18th anniversary this month, celebrating nearly two decades of pioneering industrial carbon management technology. This year has been one of the most transformative in Svante’s history, defined by bold innovation, strategic partnerships, and the commissioning of the world’s first commercial manufacturing facility for solid sorbent-based carbon capture and removal filters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251030974500/en/ Founded in 2007 with a vision to revolutionize how the world manages carbon dioxide emissions, Svante has grown into a cornerstone of the global carbon management industry. In 2025, that vision took a monumental leap forward with the launch of the Redwood Facility in Burnaby, BC — a 141,000-square-foot Centre of Excellence for Carbon Capture and Removal. This first-of-its-kind manufactu
Ireland Unveils Seven New Halloween Experiences30.10.2025 15:00:00 CET | Press release
More celebrations than ever across the island of Ireland – the true Home of Halloween With seven brand-new Halloween hubs or experiences launching across the island this month, Ireland has truly become the ultimate destination to celebrate Halloween in 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251022209535/en/ Derry Halloween Festival, County Derry~Londonderry Ireland’s Halloween Season Rooted in the ancient Celtic festival of Samhain, Halloween originated in Ireland more than 2,000 years ago and, this year, the island of Ireland is expanding its celebration like never before. With over 340 events planned across the island to celebrate this year, Halloween in Ireland is fast becoming a bucket-list travel experience. Seven new Halloween hubs join existing flagship events across the island of Ireland including the Púca Festival in County Meath and Derry Halloween in Derry-Londonderry which together welcomed over 169
Staloral® Birch Phase III Study Successfully Meets Primary Endpoint, Demonstrating Efficacy in Children and Adolescents30.10.2025 14:56:00 CET | Press release
Stallergenes Greer, a global leader in allergy therapeutics, announced today that its Phase IIIb clinical study (YOBI, YOung patients and BIrch allergy), designed to confirm the safety and efficacy of Staloral® Birch in children and adolescents with birch pollen-induced allergic rhino-conjunctivitis (ARC), with or without asthma, has successfully achieved its primary endpoint. The trial enrolled 553 children aged 5 -17 years with moderate to severe birch pollen-induced ARC, with or without asthma, across 64 sites in 12 European countries and assessed the efficacy and safety of Staloral® birch 300IR daily maintenance dose administered pre-and co-seasonally over two consecutive birch pollen seasons. The YOBI study successfully met its primary endpoint, demonstrating the efficacy of Staloral® Birch in a paediatric population (5-17) with a 41% improvement in the ARC total combined score during the second pollen season compared to placebo. These results were highly statistically significant
Debiopharm Forges AI-powered Alliance With NetTargets to Pioneer Dual-payload ADCs Against Drug-resistant Cancers30.10.2025 14:00:00 CET | Press release
An Alliance to Combat Resistance: Debiopharm and NetTargets will collaborate to develop next-generation, dual-payload Antibody-Drug Conjugates (ADCs) designed to overcome acquired resistance mechanisms in difficult-to-treat cancers. AI-Powered Precision: The collaboration combines NetTargets' proprietary AI discovery platform—to identify synergistic drug pairings—with Debiopharm’s MLINK Duo technology for coordinated delivery of two distinct warheads on a single ADC. Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based, biopharmaceutical company dedicated to developing innovative therapies that respond to high unmet medical needs, today announced a strategic research collaboration with NetTargets (www.net-targets.com), a South Korean biotech company specializing in AI-enhanced systems biology for drug discovery, to rationally design and advance the discovery of novel, synergistic drug combinations for Debiopharm’s next-generation Antibody-Drug Conjugates (ADCs). This allianc
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom